Abhishek Yadav

You are replaceable at work, but you are NOT replaceable at home. A beautiful and poignant reflection that applies to all clinicians.

@drakashmathur @DrAshish_Kumar @HMandavdhare @drvishal82 @DrJimilShah @anupam_gastro @Samanta_JayPGI @miNitinjagtap @jearth_vaneet Thank you sir 🙏

@aby10GI @DrAshish_Kumar @HMandavdhare @drvishal82 @DrJimilShah @anupam_gastro @Samanta_JayPGI @miNitinjagtap @jearth_vaneet Great work. Many congratulations dear. 🙌

Grateful and humbled to share that our study from PGI Chandigarh 🇮🇳has been published in BMJ Gut 🇬🇧 This milestone wouldn’t have been possible without the constant guidance, support, and mentorship of my respected teachers and guides. @HMandavdhare @drvishal82 @DrJimilShah

Post-EVL care oftn overluked — but it shouldn’t B. New study in Gut shows tht PPI after EVL is a/w: • Lower rebleeding • Reduced mortality • Improved post-banding ulcer healing Post-procedure phase is as important as procedure itself. Small interventions. Big outcomes.

@riya_o94 @HMandavdhare @drvishal82 @DrJimilShah @anupam_gastro @Samanta_JayPGI @miNitinjagtap @jearth_vaneet Thank you 🙏

@aby10GI @HMandavdhare @drvishal82 @DrJimilShah @anupam_gastro @Samanta_JayPGI @miNitinjagtap @jearth_vaneet Congratulations

@DrAnuraagJ @HMandavdhare @drvishal82 @DrJimilShah @anupam_gastro @Samanta_JayPGI @miNitinjagtap @jearth_vaneet Thank you sir 🙏

@aby10GI @HMandavdhare @drvishal82 @DrJimilShah @anupam_gastro @Samanta_JayPGI @miNitinjagtap @jearth_vaneet Congratulations dude

@DrJimilShah @gi_pgi @APDW2025 @HMandavdhare @drvishal82 Thank you sir😇

@aby10GI @gi_pgi @APDW2025 @HMandavdhare @drvishal82 Congratulations dear.. Keep shining..👏🏻

Delighted to present my research from @gi_pgi PGIMER Chandigarh 🇮🇳 at @APDW2025. @HMandavdhare @drvishal82 @DrJimilShah #APDW2025 Singapore 🇸🇬.

In a TB endemic region, a trial of Anti-tubercular therapy for ileal ulcers would be

Liver testing goes prime time nejm.org/doi/full/10.10…

🚦 Hazard Ratio (HR) - your survival trial’s speedometer! 🏁 Ever seen HR = 0.7 and wondered what it really means? Let’s decode 👇 🧭 HR compares how fast bad events happen ➡️ Death, relapse, or progression - whatever the trial tracks. 📊 Interpretation: ⚖️ HR = 1 → No difference 💪 HR < 1 → Treatment slows events (good ✅) ⚠️ HR > 1 → Events faster on treatment (bad ❌) 🧩 Example: HR = 0.7 → New drug reduces risk by 30% (1 – 0.7 = 0.3) Patients live longer or progress slower ⏳ 🎯 Confidence Interval (CI) = how sure we are If it doesn’t cross 1, the result is statistically solid 💥 💡 Easy memory: Kaplan-Meier curves = what you see 👀 Hazard ratio = what you prove 🔢 #OncoTwitter #MedTwitter #ClinicalTrials #StatsSimplified @OncoAlert @esmo_open @ASCO @EricTopol @VPrasadMDMPH @DrAshishJha @tmprowell @TracyBethHoeg @akshay_pachaar @selcukorkmaz

What is the impact of ❓ GLP-1 analogues in Immune Mediated Inflammatory Disorders (IMIDs) including #IBD This 👇 comprehensive SR from our group led by @ChhaganBirda gives useful insights @drvishal82 @DrAnuraagJ sciencedirect.com/science/articl…

Location of cancers in the upper GI tract. This is why some experts advise that during OGDs, we should spend most time in the oesophagus, followed by the stomach, then duodenum (O>G>D) 💡 📸: Nigel Trudgill

Two impactful RCT presented from PGIMER Chandigarh @gi_pgi led by @HMandavdhare @drvishal82 @DrJimilShah in Berlin at #uegweek2025 #myueg

Which do you prefer?

🚨 Case Report Alert: Bleeding beyond cirrhosis! 👩‍⚕️ 54F with 6️⃣ years of GI bleeds ⚠️ Initially diagnosed: variceal bleed from cirrhosis 🔁 Multiple scopes, embolisation, even TIPS… 🩸 But bleeding persisted 🧠 Final Dx: Gastroduodenal artery–SMV fistula 🧰 Treated with superselective embolisation → bleeding resolved ✅ 📌 Lesson: Not all portal hypertension = cirrhosis! 📖 Full case in @FrontGastro_BMJ here 👉 fg.bmj.com/content/16/5/4… #LiverTwitter MedTwitter #GI #InterventionalRadiology #PortalHypertension #RareDisease #Hepatology @BASLedu @BritSocGastro @EASLnews @EASLedu @AASLDtweets @PhilSmithIsBack @dr_aditi_kumar @OTavabie @DrJMKennedy @DunnePdj @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman

Answer: Flood Syndrome in Complicated Cirrhosis A 56-year-old obese man with decompensated alcohol-related cirrhosis and refractory ascites, awaiting liver-transplantation and undergoing weekly large volume paracentesis, developed a large umbilical hernia with progressive skin ulceration over three weeks. His wife contacted telemedicine services when the hernia suddenly blew out while he strained to rise from a chair, causing ascitic fluid to spurt out – a condition known as Flood Syndrome. This rare, potentially fatal cirrhosis complication, frequently preceded by skin infection or skin necrosis in over 75% of cases, results from spontaneous hernia rupture due to increased intra-abdominal pressure. Complications include sepsis, bowel incarceration, electrolyte abnormalities, liver failure, hepatic encephalopathy, shock, and multiple organ dysfunction. Conservative management carries over 60% mortality, while surgical management has 71% postoperative morbidity and 20-60% mortality, though emergency surgery reduces mortality to 6-20%. This patient underwent emergency umbilical herniorrhaphy without mesh placement but experienced severe clinical deterioration requiring increased paracentesis frequency. Described by Frank B. Flood in 1961 nejm.org/doi/abs/10.105…

Refractory esophageal variceal bleed🩸 Failed endoscopic attempts Major clinical challenge🔥 52 year old male 👨‍🦰 ➡️Met-ALD cirrhosis ➡️Refractory UGIB Temporizing methods like SEMS (SX-ELLA Danis) effectively reduces bleed and mortality [Burke E et al. 2024] 🙌🏼 👉🏽Decreased rebleed rates 👉🏽Lower transfusion need 👉🏽Reduced adverse events @doc_arka @ajay_duseja @drsuniltaneja @pachaatt @GaneshCp95 @naveendandia @balaraja_s @HepatologyPGI

One of the largest studies in biliary brush cytology @fjseruf @AASalicilica @HUReinaSofia @IMIBIC